Table 2.
Choroidal thickness at individual locations in dilated cardiomyopathy patients and control subjects
| Variable | Study Group | M | SD | 95% CI | Range | p |
|---|---|---|---|---|---|---|
| SFCTh | DCM group | 304.03 | 63.03 | 280.5–327.57 | 145.5–405.5 | < 0.05 |
| Control group | 369.72 | 55.79 | 351.39–388.06 | 263.5–503 | ||
| Nasal CTh | DCM group | 245.87 | 68.28 | 220.37–271.36 | 129–402.5 | < 0.05 |
| Control group | 284 | 63.2 | 263.23–304.77 | 194–453 | ||
| Temporal CTh | DCM group | 291.5 | 57.12 | 270.17–312.83 | 169.5–405 | < 0.05 |
| Control group | 355.95 | 61.77 | 335.64–376.25 | 237–500 | ||
| Superior CTh | DCM group | 303.98 | 58.38 | 282.18–325.78 | 203.5–401.5 | < 0.05 |
| Control group | 357.58 | 50.87 | 340.86–374.3 | 257–460.5 | ||
| Inferior CTh | DCM group | 290.92 | 52.59 | 271.28–310.55 | 180–404 | < 0.05 |
| Control group | 344.96 | 48.48 | 329.03–360.89 | 255–499.5 |
M mean, SD standard deviation, CI confidence interval, SFCTh subfoveal choroidal thickness, CTh choroidal thickness